Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diet vs Supplement for Potassium in Hypertension
NCT03809884Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Dec 2019
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of potassium citrate in hypertension (HTN) (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Successful increase in potassium intake at 4 weeks. Started Dec 2019; status: completed.
02
Drugs
potassium citrate
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03809884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809884.